This interview features Dr Deborah Rathjen, CEO and managing director of Bionomics
In this video interview, Dr Deborah Rathjen discusses how Bionomics harnesses innovation to enhance the drug pipeline, and the firm’s recent R&D collaboration for the treatment of cognitive dysfunction in Alzheimer’s patients.
This content is provided by OTC Markets and did not involve IR Magazine journalists.
